A 65-year-old retired nurse said she had got her life back thanks to a new drug used to treat Parkinson's disease which ...

The origin of many diseases such as Alzheimer's or Parkinson's can be found at the molecular level in our body, in other ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

Nilotinib, a drug approved by the US Food and Drug Administration (FDA) to treat chronic myeloid leukemia ... and the ...

This new treatment offers an alternative to oral medications, which can become less effective as Parkinson’s progresses. Robert Hauser, MD, a neurologist and Parkinson’s specialist ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

A 65-year-old retired nurse said she had got her life back thanks to a new drug used to treat Parkinson's disease which controls tremors. Jan Fuller, who lives in Hopton-on-Sea near Great Yarmouth ...